Dren Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibody therapeutics for oncology and autoimmune diseases, self-described as pioneering in its field.
investor of
Metrics
marketPRIVATE
msh_idCOM:DRENBIO
localeus
websitehttps://www.drenbio.com/
source_refaea676b6-2bc2-4fd9-af43-6b75abc12832
products_or_servicesNovel antibody therapeutics for oncology and autoimmune diseases, pipeline of clinical and preclinical programs.
United States